AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK ® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic ...